Literature DB >> 14067474

HYPERCALCEMIA IN PATIENTS WITH MALIGNANT LYMPHOMA.

A M MOSES, H SPENCER.   

Abstract

Entities:  

Keywords:  HODGKIN'S DISEASE; HYPERCALCEMIA; LYMPHOSARCOMA; SARCOMA, RETICULUM CELL

Mesh：

Year:  1963        PMID： 14067474     DOI： 10.7326/0003-4819-59-4-531

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  Hypercalcaemic stupor as a presentation of lymphosarcoma.

Authors:  G D Schott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-04       Impact factor: 10.154

Review 2.  [Ectopic paraneoplastic endocrinopathies associated with water-electrolyte balance disorders].

Authors:  K Hayduk; W Kaufmann
Journal:  Klin Wochenschr       Date:  1973-04-15

3.  Canine lymphosarcoma: a model for study of the hypercalcemia of cancer.

Authors:  H Heath; R E Weller; G R Mundy
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

4.  [Significance of metabolic parameters in Hodgkin's disease (author's transl)].

Authors:  J Oertel; H Gerhartz
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-06-15

5.  Hypercalcaemia associated with adenocarcinoma of kidney without demonstrable bone lesions.

Authors:  W H Thomson; A B Karat
Journal:  Br Med J       Date:  1966-09-24

6.  Lymphoma and hypercalcemia in a pediatric orthotopic liver transplant patient.

Authors:  P Nakazato; C O Esquivel; A H Urbach; L Makowka; V Scantlebury; R Jaffe; T E Starzl
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

7.  Hypercalcaemia due to hyperparathyroidism in a patient with chronic renal failure and renal carcinoma.

Authors:  J J Szwed; L J Gott; R E Lempke; I S Seo
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

8.  Hypercalcaemia in malignant lymphoma.

Authors:  M Greaves; B W Hancock
Journal:  Postgrad Med J       Date:  1980-01       Impact factor: 2.401

9.  Lymphoma with hypercalcemia.

Authors:  I R Walker
Journal:  Can Med Assoc J       Date:  1974-11-02       Impact factor: 8.262
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.